Recruitment

Recruitment Status
Completed

Inclusion Criterias

Bodyweight was more than 50 kg with ideal body weight within ±30%
Fasting blood glucose levels less than 100 mg/dL and an oral glucose tolerance test (OGTT) less than 140 mg/dL
Able to give informed consent
...
Bodyweight was more than 50 kg with ideal body weight within ±30%
Fasting blood glucose levels less than 100 mg/dL and an oral glucose tolerance test (OGTT) less than 140 mg/dL
Able to give informed consent
triglyceride (TG) levels less than 200 mg/dL
Males, 19~60years old

Exclusion Criterias

Alcohol consumption above 21 units per week or abnormal screening laboratory test
Medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
Participation in any other clinical trials within past 2 months
...
Alcohol consumption above 21 units per week or abnormal screening laboratory test
Medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
Participation in any other clinical trials within past 2 months
Major medical illness such as cardiovascular, neurologic, psychiatric, renal, pulmonary and hepatic diseases
Poor vital sign (systolic blood pressure: below 100 mmHg or above 150 mmHg, diastolic blood pressure: below 65 mmHg or above95 mmHg)
Being judged by the responsible physician of the local study center as unfit to participate in the study
Allergic or hypersensitive to any of the ingredients in the test products; treated with any drug within past 2 weeks
History of disease that could interfere with the test products or impede their absorption such as gastrointestinal disease or gastrointestinal surgery

Summary

Conditions
Healthy
Type
Interventional
Design
  • Allocation: Randomized
  • Intervention Model: Crossover Assignment
  • Masking: None (Open Label)
  • Primary Purpose: Treatment

Participation Requirements

Age
Between 19 years and 60 years
Gender
Only males

Description

After a 12-hour fast, oral glucose and meal tolerance was measured with blood samples drawn at times 0, 15, 30, 45, 60, 90, 120, 150 and 180 minutes and TG was at time 0, 1, 2, 3, 4, 5 and 6 hours. Serum levels of glucose, insulin, and TG were analyzed by biochemical autoanalyzer. The area under the...

After a 12-hour fast, oral glucose and meal tolerance was measured with blood samples drawn at times 0, 15, 30, 45, 60, 90, 120, 150 and 180 minutes and TG was at time 0, 1, 2, 3, 4, 5 and 6 hours. Serum levels of glucose, insulin, and TG were analyzed by biochemical autoanalyzer. The area under the curve (AUC) changes in blood glucose, TG were computed by the trapezoidal method. Glycemic index(GI): the area under the glucose response curve after consumption of a test food divided by the area under the curve after consumption of a control food containing the same amount of carbohydrate and calculated using 50 g glucose as the reference.

Inclusion Criterias

Bodyweight was more than 50 kg with ideal body weight within ±30%
Fasting blood glucose levels less than 100 mg/dL and an oral glucose tolerance test (OGTT) less than 140 mg/dL
Able to give informed consent
...
Bodyweight was more than 50 kg with ideal body weight within ±30%
Fasting blood glucose levels less than 100 mg/dL and an oral glucose tolerance test (OGTT) less than 140 mg/dL
Able to give informed consent
triglyceride (TG) levels less than 200 mg/dL
Males, 19~60years old

Exclusion Criterias

Alcohol consumption above 21 units per week or abnormal screening laboratory test
Medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
Participation in any other clinical trials within past 2 months
...
Alcohol consumption above 21 units per week or abnormal screening laboratory test
Medical or psychological conditions deemed by the investigators to interfere with successful participation in the study
Participation in any other clinical trials within past 2 months
Major medical illness such as cardiovascular, neurologic, psychiatric, renal, pulmonary and hepatic diseases
Poor vital sign (systolic blood pressure: below 100 mmHg or above 150 mmHg, diastolic blood pressure: below 65 mmHg or above95 mmHg)
Being judged by the responsible physician of the local study center as unfit to participate in the study
Allergic or hypersensitive to any of the ingredients in the test products; treated with any drug within past 2 weeks
History of disease that could interfere with the test products or impede their absorption such as gastrointestinal disease or gastrointestinal surgery

Locations

Jeonju, Jeollabuk-do, 560-822
Jeonju, Jeollabuk-do, 560-822

Tracking Information

NCT #
NCT01932086
Collaborators
Not Provided
Investigators
Study Director: Soo-Wan Chae, MD., PhD Chonbuk National University Hospital